Regencell Bioscience Holdings Ltd Quarterly Liabilities, Current in USD from Q2 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Regencell Bioscience Holdings Ltd quarterly Liabilities, Current history and growth rate from Q2 2020 to Q2 2024.
Regencell Bioscience Holdings Ltd Liabilities, Current for the quarter ending June 30, 2024 was $194K, a 68.1% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$194K	-$413K	-68.1%	Jun 30, 2024	20-F	2024-10-25
Q2 2023	$607K	+$29.2K	+5.05%	Jun 30, 2023	20-F	2024-10-25
Q2 2022	$578K	-$3.76M	-86.7%	Jun 30, 2022	20-F	2023-10-27
Q2 2021	$4.34M	+$1.17M	+37.1%	Jun 30, 2021	20-F	2022-10-31
Q2 2020	$3.16M			Jun 30, 2020	20-F	2021-10-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.